Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.verified

TNXP

Price:

$14.96

Market Cap:

$102.89M

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises...[Read more]

Industry

Biotechnology

IPO Date

2012-05-10

Stock Exchange

NASDAQ

Ticker

TNXP

The ROE as of April 2025 (TTM) for Tonix Pharmaceuticals Holding Corp. (TNXP) is -142.89%

According to Tonix Pharmaceuticals Holding Corp.’s latest financial reports and current stock price. The company's current ROE is -142.89%. This represents a change of 142.28% compared to the average of -58.98% of the last 4 quarters.

Tonix Pharmaceuticals Holding Corp. (TNXP) Historical ROE (quarterly & annually)

How has TNXP ROE performed in the past?

The mean historical ROE of Tonix Pharmaceuticals Holding Corp. over the last ten years is -117.44%. The current -142.89% ROE has changed 21.67% with respect to the historical average. Over the past ten years (40 quarters), TNXP's ROE was at its highest in in the September 2021 quarter at -9.16%. The ROE was at its lowest in in the June 2024 quarter at -187.10%.

Quarterly (TTM)
Annual

Average

-117.44%

Median

-101.86%

Minimum

-330.17%

Maximum

-42.19%

Tonix Pharmaceuticals Holding Corp. (TNXP) ROE by Quarter and Year

Discovering the peaks and valleys of Tonix Pharmaceuticals Holding Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 166.16%

Maximum Annual ROE = -42.19%

Minimum Annual Increase = -81.97%

Minimum Annual ROE = -330.17%

Quarterly (TTM)
Annual
YearROEChange
2024-93.18%-15.72%
2023-110.55%95.97%
2022-56.41%33.70%
2021-42.19%-29.12%
2020-59.53%-81.97%
2019-330.17%166.16%
2018-124.05%44.56%
2017-85.81%-43.97%
2016-153.16%28.32%
2015-119.35%55.99%

Tonix Pharmaceuticals Holding Corp. (TNXP) Average ROE

How has TNXP ROE performed in the past?

The current ROE of Tonix Pharmaceuticals Holding Corp. (TNXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-86.71%

5-year avg

-72.37%

10-year avg

-117.44%

Tonix Pharmaceuticals Holding Corp. (TNXP) ROE vs. Peers

How is TNXP’s ROE compared to its peers?

Tonix Pharmaceuticals Holding Corp.’s ROE is greater than Sonnet BioTherapeutics Holdings, Inc. (-408.94%), less than Onconova Therapeutics, Inc. (500.19%), greater than Palisade Bio, Inc. (-169.30%), greater than iBio, Inc. (-99.20%), greater than Jaguar Health, Inc. (-283.78%), greater than Acasti Pharma Inc. (-18.84%), greater than Diffusion Pharmaceuticals Inc. (-46.49%), greater than Vaxart, Inc. (-101.79%), greater than VBI Vaccines Inc. (-1081.80%), greater than Bright Minds Biosciences Inc. (-5.69%), greater than Virax Biolabs Group Limited (-93.93%), less than Novavax, Inc. (30.62%), greater than Inovio Pharmaceuticals, Inc. (-30306.90%), greater than Enveric Biosciences, Inc. (-219.71%), greater than CohBar, Inc. (-58.44%),

Build a custom stock screener for Tonix Pharmaceuticals Holding Corp. (TNXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonix Pharmaceuticals Holding Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tonix Pharmaceuticals Holding Corp. (TNXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tonix Pharmaceuticals Holding Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Tonix Pharmaceuticals Holding Corp.'s ROE?

How is the ROE calculated for Tonix Pharmaceuticals Holding Corp. (TNXP)?

What is the highest ROE for Tonix Pharmaceuticals Holding Corp. (TNXP)?

What is the 3-year average ROE for Tonix Pharmaceuticals Holding Corp. (TNXP)?

What is the 5-year average ROE for Tonix Pharmaceuticals Holding Corp. (TNXP)?

How does the current ROE for Tonix Pharmaceuticals Holding Corp. (TNXP) compare to its historical average?